Research Information

To assess detoxification efficacy, our medicines were subjected to rigorous trials upon animals of various species before clinical applications.

Alcohol Addiction (Primates)

Medicines were tested on monkeys. Experimental neurosis was developed by subjecting them to neurotogenic trauma (rubber snake in food). When mildly intoxicated with 1.5 ml/kg alcohol, the neurosis disintegrated, leading to addiction.

Result: Monkeys divided into two groups. The group given Detoxin showed significant recovery compared to the Placebo group.

Morphine Dependence (Mice)

Experiment conducted on 60 Albino mice. They were given Morphine HCL 20 mg/kg. About 4 hours later, they were divided into two groups (Detoxin vs Placebo) and then given Nalaxone.

Result: No withdrawal symptoms were found in the mice treated with Detoxin.

Barbiturates (Cats)

Samples of 20 cats were given Sodium Barbital 95 mg/kg twice daily, increasing to 200 mg/kg over 180 days. They were then deprived of the drug and divided into two groups.

Result: The group treated with Detoxin recovered smoothly compared to the Placebo group.

Human Clinical Trials

192 cases of addicts of various types were studied for 1 year. The study covered Age, Educational Status, Profession, Marital Status, and Addiction type.

Directly administering Detoxin to the control group was not considered necessary as effect gets nullified while testing potencies. The study confirmed efficacy across diverse patient profiles including those addicted to smoking/chewing tobacco, alcohol, cannabis, sedatives, hypnotics, and antidepressants.